Synthesis of characteristic Mycobacterium peptidoglycan (PGN) fragments utilizing with chemoenzymatic preparation of meso-diaminopimelic acid (DAP), and their modulation of innate immune responses
Synthesis of characteristic Mycobacterium peptidoglycan (PGN) fragments utilizing with chemoenzymatic preparation of meso-diaminopimelic acid (DAP), and their modulation of innate immune responses
a new synthetic method for an orthogonally protected meso-DAP derivative, and then we constructed the glycopeptide structures. The ability of these fragments to stimulate human Nod1, as well as differences in Nod1 recognition of the variety of synthesized ligand structures were examined. The results showed that the substitution of the N terminus of iE-DAP is necessary for stronger Nod1 recognition
Urethanes and ureas that induce cytokine production
申请人:AMERICAN CYANAMID COMPANY
公开号:EP0652228A1
公开(公告)日:1995-05-10
The invention relates to novel ureas and urethanes of Formula I:
which stimulate cytokine production and may be used to accelerate recovery from neutropenia accompanying radio- or chemotherapy, bone marrow transplantation, or infections. Compounds in the invention or pharmaceutical compositions employing these compounds may be useful in the treatment of cancer, AIDS, aplastic anemia, myelodysplastic syndrome, and infectious diseases, and in the enhancement of immune response.
本发明涉及式 I 的新型脲和氨酯:
它们可刺激细胞因子的产生,并可用于加速从伴随放疗或化疗、骨髓移植或感染的中性粒细胞减少症中恢复过来。本发明中的化合物或采用这些化合物的药物组合物可用于治疗癌症、艾滋病、再生障碍性贫血、骨髓增生异常综合症和传染病,以及增强免疫反应。
Synthesis of characteristic Mycobacterium peptidoglycan (PGN) fragments utilizing with chemoenzymatic preparation of meso-diaminopimelic acid (DAP), and their modulation of innate immune responses
作者:Qianqian Wang、Yusuke Matsuo、Ambara R. Pradipta、Naohiro Inohara、Yukari Fujimoto、Koichi Fukase
DOI:10.1039/c5ob02145f
日期:——
CharacteristicMycobacteriumpeptidoglycan fragments were comprehensively synthesized and their weaker immunostimulationviaNod1 and Nod2 was shown.